The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
30-Dec-21
$100 million
Target:
Photonics Division of Intevac
Acquiror:
EOTech LLC
Advised Intevac, a leading developer of thin-film processing systems for the electronics market and high-sensitivity digital sensors for the defense industry, on the sale of its Photonics division to EOTech, a manufacturer of holographic sighting systems and accessories for military and commercial customers
01-Dec-21
Pending
Undisclosed
Target:
Finalsite
Acquiror:
Veritas Capital
Advising Bridge Growth Partners, a private equity firm focused on technology investments, on the sale of Finalsite, a leading SaaS platform serving K-12 schools and universities, to Veritas Capital
26-Oct-21
Undisclosed
Target:
Oculii Corporation
Acquiror:
Ambarella, Inc.
Advised Ambarella, Inc., an AI vision silicon company, on the acquisition of Oculii Corporation, a leading developer of AI software designed to enhance radar perception
29-Sep-21
~$1.1 billion
Target:
Procaps Group
Acquiror:
Union Acquisition Corp. II (NASDAQ: LATN)
Advised Procaps Group, a leading integrated international healthcare and pharmaceutical company, on its successful business combination with Union Acquisition Corp II (NASDAQ: LATN), a LatAm-focused special purpose acquisition company. Procaps Group now trades on the Nasdaq Global Market under the ticker symbol "PROC"
20-Sep-21
Undisclosed
Target:
Faes Farma, flagship product Bilastine
Acquiror:
Hikma Specialty USA INC
Advised Faes Farma in the signing of a long-term license agreement for its flagship product Bilastine with Hikma Specialty USA INC, a subsidiary of Hikma Pharmaceuticals PLC, for the United States of America
09-Sep-21
Undisclosed
Target:
Quicken
Acquiror:
Aquiline Capital Partners
Advised Aquiline Capital Partners on its acquisition of Quicken, the best-selling personal finance software in the U.S., from H.I.G. Capital
25-Aug-21
$415 million
Target:
GT Advanced Technologies
Acquiror:
onsemi
Advising onsemi (NASDAQ: ON), a global leader in the development, manufacture and supply of semiconductor components for power, analog, sensor and connectivity solutions, on the acquisition of GT Advanced Technologies, Inc. (“GTAT”), a producer of silicon carbide (SiC)
05-Aug-21
$2 billion
Target:
Score Media and Gaming, Inc.
Acquiror:
Penn National Gaming, Inc.
Advising the Board of Directors of Score Media and Gaming (“theScore”), a leading digital media and sports betting and technology company, regarding the acquisition of theScore by Penn National Gaming
05-Jul-21
Undisclosed
Target:
American Stock Transfer & Trust Company
Acquiror:
Siris Capital Group LLC
Advised Siris Capital, a private equity firm focused on the technology sector, on its acquisition of American Stock Transfer & Trust Company, a leading technology-enabled full service professional services firm
01-Jun-21
Undisclosed
Target:
VEP Healthcare
Acquiror:
U.S. Acute Care Solutions
Advised VEP Healthcare, a leading, physician-owned provider of clinical management services in emergent and inpatient settings in the United States, on its merger with U.S. Acute Care Solutions
27-May-21
$1.4 billion
Target:
Equiniti Group PLC
Acquiror:
Siris Capital Group LLC
Advised Siris Capital, a private equity firm focused on the technology sector, on its recommended 180p cash offer for Equiniti Group PLC, a technology-led services and payments specialist
10-May-21
$280 million
Target:
Photon Control
Acquiror:
MKS Instruments
Advising MKS, a global provider of instruments, systems, subsystems and process control solutions, on the acquisition of Photon Control, a Canadian manufacturer of fiber optic measurement solutions used in semiconductor wafer fabrication
07-May-21
N/A
Target:
MindPath Care Centers
Acquiror:
Community Psychiatry
Advised Community Psychiatry, a leading provider of outpatient behavioral health services with a focus on high-quality clinically-driven care, on its acquisition of MindPath Care Centers, deepening its national presence to more than 350 providers across the US
08-Apr-21
$651 million
Target:
Whinstone Inc. – Subsidiary of Northern Data AG
Acquiror:
Riot Blockchain Inc.
Advising Northern Data AG, a Germany based developer and operator of high-performance computing (“HPC”) infrastructure solutions, on the sale of its U.S. subsidiary Whinstone Inc., an HPC data center operator based in Rockdale, Texas, to Riot Blockchain Inc., a U.S. based publicly-traded bitcoin miner
26-Feb-21
$2.0 billion
Target:
MDLIVE
Acquiror:
Cigna
Advising Cigna on the acquisition of MDLIVE, a virtual care delivery platform, by Evernorth, Cigna’s health services portfolio
24-Feb-21
Undisclosed
Target:
Resource Optimization Software Business Area of Net Insight
Acquiror:
Xytech Systems Corporation
Advising Net Insight AB, a global leader in media networks, on the divestment of its resource optimization software business area, doing business as “ScheduALL” to Xytech Systems Corporation
09-Feb-21
Undisclosed
Target:
US Acute Care Solutions
Acquiror:
Apollo Hybrid Value Fund
Advising US Acute Care Solutions, the largest majority physician-owned emergency medicine practice in the United States, on its recapitalization and buyout of minority partner, Welsh Carson
29-Dec-20
$110 million
Target:
Biogix, Inc.
Acquiror:
Alliance Pharma plc
Advised Biogix, Inc., a leader in the development, research and distribution of clinically tested menopause and perimenopause supplements in the U.S. under the flagship brand Amberen, on its sale to Alliance Pharma plc
15-Sep-20
$NA
Target:
Surgery Partners’ Anesthesia Services
Acquiror:
NorthStar Anesthesia
Advised Surgery Partners, a leading owner and operator of surgical facilities, on the divestiture of its anesthesia services business to NorthStar Anesthesia
12-Aug-20
$225 million
Target:
340B Link
Acquiror:
Omnicell
Advising Omnicell, a leading provider of medication management solutions and adherence tools for health systems and pharmacies, on the acquisition of the 340B Link business from Pharmaceutical Strategies Group (PSG)
03-Aug-20
$110 million
Target:
Pelco Incorporated
Acquiror:
Motorola Solutions, Inc.
Advised Motorola Solutions, Inc., a global leader in mission-critical communications and analytics, on the acquisition of Pelco Incorporated, a U.S.-based provider of video security solutions
01-Jul-20
$225 million
Target:
Cello Health plc
Acquiror:
Arsenal Capital Partners
Advised Cello Health, a global healthcare-focused advisory firm, on a recommended cash offer for its entire issued share capital from Arsenal Capital Partners, a specialised private equity firm based in the United States
10-Jun-20
$3.9 billion
Target:
Global collaboration agreement with Genmab A/S
Acquiror:
AbbVie, Inc
Advised AbbVie, Inc, an NYSE-listed global biopharmaceutical company, on a broad collaboration with Genmab A/S, a leading Danish-listed biotechnology company, to jointly develop and commercialise three next-generation bispecific antibody programs
03-Jun-20
$NA
Target:
Cerner RevWorks
Acquiror:
R1 RCM
Advised Cerner Corporation, a leader in healthcare information technology, on its sale of its RevWorks revenue cycle management services business to R1 RCM, a leading provider of technology-enabled RCM services
23-Mar-20
$68 million
Target:
Abacus Health Products, Inc.
Acquiror:
Charlotte’s Web Holdings, Inc.
Advised Abacus Health Products, Inc., a leader in over-the-counter (“OTC”) topical products combining active pharmaceutical ingredients with cannabidiol (“CBD”) hemp extract, on its sale to the Charlotte’s Web Holdings, Inc., a market leader in hemp-derived CBD wellness products.